BYRN Q3 Deep Dive: Margin Improvements and Marketing Initiatives Offset Revenue Decline
Non-lethal weapons company Byrna (NASDAQ:BYRN) missed Wall Street’s revenue expectations in Q3 2026, with sales falling 45.7% year on year to $15.3 million. Its non-GAAP loss of $0.08 per share was 59.1% above analysts’ consensus estimates.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo